ALPS Advisors’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

ALPS Advisors’s Portfolio RXDX Stock Details RXDX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell
2023 Q1	$3.36M	Buy
2022 Q4	$3.14M	Buy
2022 Q3	$1.32M	Sell
2022 Q2	$656K	Sell
2022 Q1	$1.52M	Sell
2021 Q4	$1.78M	Buy